Neocortical dialysate monoamines of rats after acute, subacute, and chronic liver shunt.
Intracerebral microdialysis was applied to monitor the neocortical extracellular levels of the aromatic amino acids phenylalanine, tyrosine, and tryptophan, the neurotransmitters dopamine (DA), noradrenaline (NA), and serotonin (5-HT), and the metabolites 3,4-dihydroxyphenylacetic acid (DOPAC) and 5-hydroxyindole-3-acetic acid (5-HIAA) in rats with various forms of experimental hepatic encephalopathy (HE). The extracellular aromatic amino acid levels were clearly increased in acute, subacute, and chronic HE. No changes compared with controls in the neocortical DA release could be detected in the three experimental HE rat models investigated. The NA release showed a significant increase only in the subacute HE group. These data suggest that HE may not be associated with any major reduction of neocortical DA or NA release as previously suggested. In acute and subacute HE, decreased extracellular DOPAC but elevated 5-HIAA concentrations were seen. In chronic HE, elevations of both DOPAC and 5-HIAA were observed. Neocortical 5-HT release did not change in subacute and chronic HE, whereas it decreased in acute HE compared with control values. Significant increase in extracellular concentrations of 5-HIAA and of the 5-HIAA/5-HT ratio in the present study are in agreement with previously reported increases in 5-HT turnover in experimental HE. However, a substantially increased 5-HT turnover in experimental HE does not appear to be related to an increase in neuronal neocortical 5-HT release.
Bergqvist
P B
PB
Department of Clinical Pharmacology, Lund University Hospital, Sweden.
Vogels
B A
BA
Bosman
D K
DK
Maas
M A
MA
Hjorth
S
S
Chamuleau
R A
RA
Bengtsson
F
F
D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism; D000208:Acute Disease; D000596:Amino Acids / Q000378:metabolism*; D000641:Ammonia / Q000097:blood; D000818:Animals; D015306:Biogenic Monoamines / Q000378:metabolism*; D001835:Body Weight; D002540:Cerebral Cortex / Q000378:metabolism*; D002908:Chronic Disease; D003956:Dialysis; D004195:Disease Models, Animal; D004298:Dopamine / Q000378:metabolism; D005110:Extracellular Space / Q000378:metabolism; D006501:Hepatic Encephalopathy / Q000378:metabolism*; D006897:Hydroxyindoleacetic Acid / Q000378:metabolism; D008297:Male; D009638:Norepinephrine / Q000378:metabolism; D010649:Phenylalanine / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D012701:Serotonin / Q000378:metabolism; D014364:Tryptophan / Q000378:metabolism; D014443:Tyrosine / Q000378:metabolism
D000596:Amino Acids; D015306:Biogenic Monoamines; D015102:3,4-Dihydroxyphenylacetic Acid; D012701:Serotonin; D014443:Tyrosine; D010649:Phenylalanine; D006897:Hydroxyindoleacetic Acid; D000641:Ammonia; D014364:Tryptophan; D004298:Dopamine; D009638:Norepinephrine